On 26 March 2026 (I ZR 74/25, press release 55/2026), the Federal Court of Justice held that a platform listing complaints for which cannabis therapy could be considered and arranging doctor appointments infringes the ban on advertising prescription medicines to the public (Section 10(1) HWG), actionable under Section 3a UWG. The ban covers not only a specific product but also promoting a therapy with prescription medicines. Telemedicine providers and health platforms should review indication lists, forms and campaigns carefully.
Die Werberechtler · Wettbewerbs- und Werberecht
Die Werberechtler · Unfair competition and advertising law
Federal Court of Justice: cannabis platform breaches public advertising ban
Ihr Ansprechpartner
Frist läuft oder Kampagne steht an?
Unsere Fachanwälte für gewerblichen Rechtsschutz melden sich in der Regel binnen eines Werktags – bei Abmahnungen und einstweiligen Verfügungen mit Vorrang.
Your contacts
Deadline running or campaign coming up?
Our certified IP specialists usually respond within one business day – warning letters and injunctions with priority.